BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24863378)

  • 1. Our 2014 approach to candidaemia.
    Koehler P; Tacke D; Cornely OA
    Mycoses; 2014 Oct; 57(10):581-3. PubMed ID: 24863378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).
    Chiotos K; Vendetti N; Zaoutis TE; Baddley J; Ostrosky-Zeichner L; Pappas P; Fisher BT
    J Antimicrob Chemother; 2016 Dec; 71(12):3536-3539. PubMed ID: 27494929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group.
    Doğan Ö; Yeşilkaya A; Menekşe Ş; Güler Ö; Karakoç Ç; Çınar G; Kapmaz M; Aydın M; Keske Ş; Şahin S; Hacıseyitoğlu D; Yalçın D; Tekin S; Ataç N; Albayrak Ö; Aksu ED; Can F; Ergönül Ö
    Int J Antimicrob Agents; 2020 Jul; 56(1):105992. PubMed ID: 32335275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes.
    Shah DN; Yau R; Weston J; Lasco TM; Salazar M; Palmer HR; Garey KW
    J Antimicrob Chemother; 2011 Sep; 66(9):2146-51. PubMed ID: 21700622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.
    Arendrup MC; Dzajic E; Jensen RH; Johansen HK; Kjaeldgaard P; Knudsen JD; Kristensen L; Leitz C; Lemming LE; Nielsen L; Olesen B; Rosenvinge FS; Røder BL; Schønheyder HC
    Clin Microbiol Infect; 2013 Aug; 19(8):E343-53. PubMed ID: 23607326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between incidence of candidaemia and consumption of antifungal agents at a medical centre in Taiwan.
    Lai CC; Chu CC; Wang CY; Tsai HY; Cheng A; Lee YC; Huang YT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2012 Oct; 40(4):349-53. PubMed ID: 22819796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial antifungal strategy does not correlate with mortality in patients with candidemia.
    Murri R; Scoppettuolo G; Ventura G; Fabbiani M; Giovannenze F; Taccari F; Milozzi E; Posteraro B; Sanguinetti M; Cauda R; Fantoni M
    Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):187-93. PubMed ID: 26634352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
    Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
    Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of invasive candidiasis: between guidelines and daily clinical practice.
    Tagliaferri E; Menichetti F
    Expert Rev Anti Infect Ther; 2015 Jun; 13(6):685-9. PubMed ID: 25818660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida infections in non-neutropenic children after the neonatal period.
    Hacimustafaoglu M; Celebi S
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidaemia in the non-neutropenic patient: a critique of the guidelines.
    Deshpande A; Gaur S; Bal AM
    Int J Antimicrob Agents; 2013 Oct; 42(4):294-300. PubMed ID: 24016797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.
    Fernández-Ruiz M; Aguado JM; Almirante B; Lora-Pablos D; Padilla B; Puig-Asensio M; Montejo M; García-Rodríguez J; Pemán J; Ruiz Pérez de Pipaón M; Cuenca-Estrella M; ; ;
    Clin Infect Dis; 2014 May; 58(10):1413-21. PubMed ID: 24642553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies.
    Kontoyiannis DP; Bassetti M; Nucci M; Capparella MR; Yan JL; Aram J; Hogan PA
    Mycoses; 2017 Oct; 60(10):663-667. PubMed ID: 28597967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management.
    Mellinghoff SC; Hoenigl M; Koehler P; Kumar A; Lagrou K; Lass-Flörl C; Meis JF; Menon V; Rautemaa-Richardson R; Cornely OA
    Mycoses; 2018 May; 61(5):326-330. PubMed ID: 29325218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
    Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
    J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of echinocandins versus fluconazole for treatment of persistent candidemia: A time-dependent analysis.
    Lin KY; Chen PY; Chuang YC; Wang JT; Sun HY; Sheng WH; Chen YC; Chang SC
    J Infect; 2018 Sep; 77(3):242-248. PubMed ID: 29932963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.
    Pfaller M; Neofytos D; Diekema D; Azie N; Meier-Kriesche HU; Quan SP; Horn D
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):323-31. PubMed ID: 23102556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study.
    Eschenauer GA; Carver PL; Lin SW; Klinker KP; Chen YC; Potoski BA; Shields RK; Clancy CJ; Nguyen MH; Lam SW
    J Antimicrob Chemother; 2013 Apr; 68(4):922-6. PubMed ID: 23212115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [First case report of catheter-related fungemia by Candida nivariensis in the Iberian Peninsula].
    López-Soria LM; Bereciartua E; Santamaría M; Soria LM; Hernández-Almaraz JL; Mularoni A; Nieto J; Montejo M
    Rev Iberoam Micol; 2013 Jan; 30(1):69-71. PubMed ID: 22982698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.